Brausi, M. Et Al. 2012. BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER. AUA Annual Meeting , (Georgia, United States Of America).

Brausi, M., Oddens, J., Sylvester, R., Bono, A., van de Beek, C., van Andel, G., ... Gontero, P.(2012). BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER . AUA Annual Meeting, Georgia, United States Of America

Brausi, Maurizio Et Al. "BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER," AUA Annual Meeting, Georgia, United States Of America, 2012

Brausi, Maurizio Et Al. "BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER." AUA Annual Meeting , Georgia, United States Of America, 2012

Brausi, M. Et Al. (2012) . "BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER." AUA Annual Meeting , Georgia, United States Of America.

@conferencepaper{conferencepaper, author={Maurizio Brausi Et Al. }, title={BACILLUS CALMETTE-GUERIN: ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER}, congress name={AUA Annual Meeting}, city={Georgia}, country={United States Of America}, year={2012}}